Literature DB >> 29509571

Fulminant Acute Respiratory Distress Syndrome After Calcineurin Inhibitor-belatacept Conversion in a Lung Transplant Recipient.

Olivier Brugière1, Aurelie Cazes2, Laure Champion3, MArie-Pierre Debray4, Gisèle Mourin1, Bruno Crestani5, Deborah Sroussi1, Vincent Bunel1, Gilles Jebrak1, Gaëlle Dauriat1, Yves Castier6, Pierre Mordant6, Brice Lortat-Jacob7, Sylvain Jean-Baptiste7, Lila Bouadma8, Hervé Mal1, Gabriel Thabut1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29509571     DOI： 10.1097/TP.0000000000002153

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  3 in total

1.  A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation.

Authors:  Howard J Huang; Kenneth Schechtman; Medhat Askar; Cory Bernadt; Brigitte Mittler; Peter Dore; Chad Witt; Derek Byers; Rodrigo Vazquez-Guillamet; Laura Halverson; Ruben Nava; Varun Puri; Andrew Gelman; Daniel Kreisel; Ramsey R Hachem
Journal:  Am J Transplant       Date:  2022-03-22       Impact factor: 9.369

Review 2.  Acute kidney injury after lung transplantation: a narrative review.

Authors:  Lei Jing; Wenhui Chen; Lijuan Guo; Li Zhao; Chaoyang Liang; Jingyu Chen; Chen Wang
Journal:  Ann Transl Med       Date:  2021-04

3.  Effect of MMF Immunosuppression Based on CNI Reduction on CNI-Related Renal Damage after Lung Transplantation.

Authors:  Chunxai Tang; Wei Wang; Yuxi Xue; Junwei Yang
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.